Why big pharma has abandoned antibiotics

  27 October 2020

Despite the clear need for more antimicrobial agents, such drugs have not been forthcoming. Fewer new antibiotics are reaching the market; the last entirely original class of antibiotic was discovered in the late 1980s. One reason is that discovering and bringing antibiotics to market is often not profitable for pharmaceutical companies.

 

Further reading: Nature
Author(s): Benjamin Plackett
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed